Author

S. Bloor

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Approach:biophysical modeling· 1 Research Focus:cell type annotation· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:drug response / drug discovery· 1 Research Focus:protein folding & dynamics· 1 Assay:proteomics· 1

Frequent Co-Authors

P. J. Lehner· 2 shared A. P. Davenport· 1 shared C. H. Douse· 1 shared D. Nyimanu· 1 shared E. J. Greenwood· 1 shared E. L. Robinson· 1 shared G. Strachan· 1 shared I. A. Tchasovnikarova· 1 shared

Activity by Year

2017-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPharmacology & Toxicology

P. J. Lehner

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Human embryonic stem cell-derived cardiomyocytes express SARS-CoV-2 host entry proteins: screen to identify inhibitors of infection

T. L. Williams, M. T. Colzani, R. G. Macrae, E. L. Robinson, S. Bloor, E. J. Greenwood, J. R. Zhan, G. Strachan, R. E. Kuc, D. Nyimanu, J. J. Maguire, P. J. Lehner, S. Sinha, A. P. Davenport

The paper identifies benztropine and DX600 as inhibitors of SARS-CoV-2 infection using a screening platform with human embryonic stem cell-derived cardiomyocytes.

bioRxiv · Jan 22, 2021 · PreprintPharmacology & Toxicology

Neuropathic mutations in MORC2 perturb GHKL ATPase dimerization dynamics and epigenetic silencing by multiple structural mechanisms

C. H. Douse, S. Bloor, Y. Liu, M. Shamin, I. A. Tchasovnikarova, R. T. Timms, P. J. Lehner, Y. Modis

This study investigates how neuropathic mutations in MORC2 disrupt dimerization dynamics and epigenetic silencing through structural changes in the ATPase module.

bioRxiv · Oct 2, 2017Biochemistry